Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience
- PMID: 10694644
- DOI: 10.1002/(sici)1096-9098(200002)73:2<87::aid-jso6>3.0.co;2-p
Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience
Abstract
Background and objectives: There are many factors thought to have an influence on the prognosis of osteosarcoma that have been reported in the literature. Their significance, however, still remains controversial in most cases. Experience with osteogenic sarcoma (OS) was reviewed in order to evaluate surgical results and survival and to determine the prognostic factors.
Methods: Ninety-six patients with high-grade osteosarcoma of the extremities were treated between 1986 and 1997 in the authors' institution. They were divided into 3 groups: In group I, all 75 patients with nonmetastatic OS received intensive chemotherapy (high-dose methotrexate, doxorubicin, ifosfamide, and cisplatin) and underwent surgery. In group II, 9 patients already had metastases at the time of referral. In group III, 12 patients received chemotherapy in delayed or suboptimal form. Results and Conclusions In group I, there were local recurrences in 3 patients (7%) and metastases in 8 patients (20%) with limb-saving, whereas these numbers were 1 (3%) and 14 (38%) in those who had amputation. The 5-year disease-free survival (DFS) was 72% and 69% in the limb-saving and amputation groups, respectively. In groups II and III, 5-year DFS was extremely poor, 10% and 20% only, underlining the importance of stage and intensity of chemotherapy, respectively. With univariate analysis, sex, duration of symptoms, and radiographic appearance of OS had no prognostic value, whereas tumor volume <60 cm(3), wide or radical surgical margin, distal location of OS, cartilagineous ground substance <20%, and response to chemotherapy were positive prognostic factors. The last 4 variables maintained their significance in the multivariate Cox model as well. Age >30 years showed indirect negative influence on the final outcome through enhanced intolerability to the drugs and less cooperability of the patients. The results on survival with limb-saving surgery were well comparable with those of amputation.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
[Results of limb-saving surgery and prognostic factors in patients with osteosarcoma].Orv Hetil. 2000 Oct 1;141(40):2175-82. Orv Hetil. 2000. PMID: 11064568 Hungarian.
-
Limb-sparing in patients with non-metastatic high-grade osteosarcoma.J BUON. 2009 Jan-Mar;14(1):63-9. J BUON. 2009. PMID: 19373949
-
Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt.J Pediatr Hematol Oncol. 2020 Mar;42(2):e66-e78. doi: 10.1097/MPH.0000000000001506. J Pediatr Hematol Oncol. 2020. PMID: 31107367
-
Current management, local management, and survival statistics of high-grade osteosarcoma. Experience in Japan.Clin Orthop Relat Res. 1991 Sep;(270):72-8. Clin Orthop Relat Res. 1991. PMID: 1884562 Review.
-
Adjuvant and neoadjuvant chemotherapy in osteosarcoma.Chir Organi Mov. 2001 Oct-Dec;86(4):253-68. Chir Organi Mov. 2001. PMID: 12056242 Review. English, Italian.
Cited by
-
The metastasectomy and timing of pulmonary metastases on the outcome of osteosarcoma patients.Clin Med Oncol. 2009 Sep 14;3:99-105. doi: 10.4137/cmo.s531. Clin Med Oncol. 2009. PMID: 20689616 Free PMC article.
-
EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.Tumour Biol. 2014 Jun;35(6):5159-65. doi: 10.1007/s13277-014-1668-8. Epub 2014 Jan 31. Tumour Biol. 2014. PMID: 24481662
-
Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.Indian J Orthop. 2014 May;48(3):247-54. doi: 10.4103/0019-5413.132497. Indian J Orthop. 2014. PMID: 24932029 Free PMC article.
-
Osteosarcoma: improvement in survival limited to high-grade patients only.J Cancer Res Clin Oncol. 2011 Apr;137(4):597-607. doi: 10.1007/s00432-010-0923-7. Epub 2010 Jun 1. J Cancer Res Clin Oncol. 2011. PMID: 20514491 Free PMC article.
-
Update on Osteosarcoma.Curr Oncol Rep. 2021 Apr 21;23(6):71. doi: 10.1007/s11912-021-01053-7. Curr Oncol Rep. 2021. PMID: 33880674 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical